<DOC>
	<DOCNO>NCT01692379</DOCNO>
	<brief_summary>To evaluate hypothesis mechanical embolectomy Solitaire FR device superior medical management alone achieve favorable outcome distribution modify Rankin Scale score 90 day subject present acute large vessel ischemic stroke &lt; 8 hour symptom onset .</brief_summary>
	<brief_title>Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy Anterior Circulation Stroke Within 8 Hours</brief_title>
	<detailed_description>Prospective , multi-center , randomize , control , open , blinded-endpoint trial sequential design . The randomization employ 1:1 ratio mechanical embolectomy CE MARK approve stentriever Solitaire FR® versus medical management alone . Randomization do minimization process use age , baseline NIHSS , therapeutic window vessel occlusion site . For primary endpoint , subject follow 90 day post-randomization . Interim analysis perform preplanned interpret Data Safety Monitoring Board ( DSMB ) first 174 , 346 518 patient represent 25 % , 50 % 75 % plan sample size complete 90-day follow-up . The DSMB advise executive committee ( EC ) recommendation stop trial early either reason safety , efficacy , futility adjust sample size . The latter may necessary give paucity data regard natural history non-treated patient assumption regard rate favorable outcome group patient may incorrect . Of note , sample size adjustment base different expect outcomes rate permit , permit adjust sample size base change pre-specified treatment effect set 10 % . Subject population : Subjects present acute ischemic stroke within 8 hour symptom onset whose stroke attributable occlusion internal carotid proximal MCA ( M1 ) artery . Subjects either ineligible IV alteplase receive IV alteplase therapy without recanalization .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>1 . Acute ischemic stroke patient ineligible IV thrombolytic treatment treatment contraindicate ( e.g. , subject present beyond recommended time symptom onset ) , patient receive IV thrombolytic therapy without recanalization minimum 30 min start iv tPA infusion 2 . No significant prestroke functional disability ( mRS ≤ 1 ) 3 . Baseline NIHSS score obtain prior randomization must equal high 6 point 4 . Age ≥18 ≤ 85 . 5 . Occlusion ( TICI 01 ) intracranial ICA ( distal ICA T occlusion ) , MCAM1 segment tandem proximal ICA/MCAM1 suitable endovascular treatment , evidence CTA , MRA angiogram , without concomitant cervical carotid occlusion stenosis 6 . Patient treatable within eight hour symptom onset . Symptoms onset define point time patient last see well ( baseline ) . Treatment start define groin puncture . 7 . Informed consent obtain patient acceptable patient surrogate Clinical criterion 1 . Known hemorrhagic diathesis , coagulation factor deficiency , oral anticoagulant therapy INR &gt; 3.0 2 . Baseline platelet count &lt; 30.000/µL 3 . Baseline blood glucose &lt; 50mg/dL &gt; 400mg/dl 4 . Severe , sustain hypertension ( SBP &gt; 185 mm Hg DBP &gt; 110 mm Hg ) 5 . Patients coma ( NIHSS item consciousness &gt; 1 ) ( Intubated patient transfer could randomize case NIHSS obtain neurologist prior transportation ) . 6 . Seizures stroke onset would preclude obtain baseline NIHSS 7 . Serious , advanced , terminal illness anticipate life expectancy le one year . 8 . History life threaten allergy ( rash ) contrast medium 9 . Subjects receive iv tPA treatment beyond 4,5 hour begin symptom 10 . Renal insufficiency creatinine ≥ 3 mg/dl 11 . Woman childbearing potential know pregnant lactate positive pregnancy test admission . 12 . Subject participate study involve investigational drug device would impact study . 13 . Cerebral vasculitis 14 . Patients preexist neurological psychiatric disease would confound neurological functional evaluation , mRS score baseline must ≤ 1 . This exclude patient severely demented , require constant assistance nursing home type set live home fully independent activity daily live ( toileting , dress , eat , cook prepare meal , etc . ) 15 . Unlikely available 90day followup ( e.g . fix home address , visitor overseas ) . Neuroimaging criterion : 16 . Hypodensity CT restrict diffusion amount ASPECTS score &lt; 7 NCCT &lt; 6 DWI MRI . Patients 81 85 year old ASPECTS score noncontrast CT DWI MRI &lt; 9 must exclude . ASPECTS must evaluate CBV map CT Perfusion , CTA source imaging ( CTASI ) DWIMR patient whose vascular occlusion study ( CTA/MRA ) confirm qualify occlusion , perform beyond 4.5 hour last see well . 17 . CT MR evidence hemorrhage ( presence microbleeds allow ) . 18 . Significant mass effect midline shift . 19 . Evidence ipsilateral carotid occlusion , high grade stenosis arterial dissection extracranial petrous segment internal carotid artery treat prevent access intracranial clot excessive tortuosity cervical vessel preclude device delivery/deployment 20 . Subjects occlusion multiple vascular territory ( e.g. , bilateral anterior circulation , anterior/posterior circulation ) 21 . Evidence intracranial tumor ( except small meningioma ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>endovascular treatment</keyword>
	<keyword>clinical trial</keyword>
</DOC>